Transaction · 0001231919-26-000135

RA CAPITAL MANAGEMENT, L.P.

RA CAPITAL MANAGEMENT, L.P., DIR, reported a transaction classified as C at SpyGlass Pharma, Inc. involving 1806644.000000 shares. Reported holdings after the transaction were 1806644.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

CSEC transaction code CDIR
SGPSpyGlass Pharma, Inc.
Filing timeFeb 11
Trade dateFeb 09, 2026
Filing · SECView on SEC
InsiderProfile

Price performance since filing

Close on the filing date, the pre-filing context, and the forward return at standard windows
Price at filing
$27.55
Pre-filing
1mo ago1w ago1d ago -4.2%
Returns since
7d +3.4%30d -3.6%90d -12.4%180d -8.7%1y -2.4%

SGP price since this filing

30 days of pre-filing context and vertical markers at the filing date plus 7d / 30d / 90d / 180d / 1y afterwards
SGP since 2026-02-11Filed 210 days ago · 30 days of pre-filing context shaded
Loading…
Filing datePost-filing windows (7d, 30d, 90d, 180d, 1y)30 days of pre-filing context

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
C
Code C
Identifier
0001231919-26-000135
Common Stock
Transaction date
Feb 09, 2026
Filed Feb 11, 2026, 10:15 PM · 2d delay
Shares
1.80M sh
Price unknown
Estimated value
—
Computed from shares × price
Holdings after
1.80M sh
Indirect · See footnotes

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $10.0MLarge $100M
Large Holdings Increase
-4score
Filing-only score

-4

Compact filing score computed from stored Form 4 facts. Version v1.

Neutral filing signal

This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% YesOther No
Footnotes & amended
  1. F1

    All shares of the preferred stock, par value $0.00001 per share, of the Issuer automatically converted on a one-for-one basis to shares of the Issuer's common stock, par value $0.00001 per share ("Com…

  2. F2

    RA Capital Management, L.P. (the "Adviser") is the investment manager for RA Capital Healthcare Fund, L.P. (the "Fund") and RA Capital Nexus III Fund, L.P. (the "Nexus Fund III"). The general partner…

  3. F3

    Held directly by the Fund.

  4. F4

    Held directly by the Nexus Fund III.

Original filing · 0001231919-26-000135
Related transactions

0 other filings

Same reporting owner
Recent company activity

0 recent txs

SGP